Lars Hjorth
61 – 70 of 97
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: Secondary analysis of the Euro-Ewing99-R1 trial.
(
- Contribution to journal › Article
-
Mark
Teenagers and young adults with cancer in Europe: from national programmes to a European integrated coordinated project.
2015) In European Journal of Cancer Care(
- Contribution to journal › Article
-
Mark
Autoimmune diseases in Adult Life after Childhood Cancer in Scandinavia (ALiCCS).
2015) In Annals of the Rheumatic Diseases(
- Contribution to journal › Article
-
Mark
Ewing Sarcoma: Current Management and Future Approaches Through Collaboration.
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Increased health care utilization by survivors of childhood lymphoblastic leukemia is confined to those treated with cranial or total body irradiation: a case cohort study.
(
- Contribution to journal › Article
-
Mark
Long-Term Cognitive Sequelae After Pediatric Brain Tumor Related to Medical Risk Factors, Age, and Sex
(
- Contribution to journal › Article
-
Mark
Practices of Pediatric Oncology and Hematology Providers Regarding Fertility Issues: A European Survey
(
- Contribution to journal › Article
-
Mark
Cyclophosphamide Compared With Ifosfamide in Consolidation Treatment of Standard-Risk Ewing Sarcoma: Results of the Randomized Noninferiority Euro-EWING99-R1 Trial.
(
- Contribution to journal › Article
-
Mark
Challenges for Children and Adolescents With Cancer in Europe: The SIOP-Europe Agenda
(
- Contribution to journal › Article
-
Mark
Retrospektiv forskning kräver bättre digital arkivering
(
- Contribution to journal › Debate/Note/Editorial